Skip to main content

Table 2 Characteristics of the studied population

From: Molecular detection of urogenital mollicutes in patients with invasive malignant prostate tumor

 

PCa (n = 50)

BPH (n = 55)

Age (years)

 < 60

2

(4%)

5

(9%)

 60–69

9

(18%)

17

(31%)

 70–79

23

(46%)

22

(40%)

 > 79

16

(32%)

11

(20%)

PSA level (ng/ml)

 0–4

4

(8%)

17

(31%)

 4.1–10

7

(14%)

17

(31%)

 10.1–20

8

(16%)

14

(25%)

 > 20

31

(62%)

7

(13%)

Gleason score

 6–7

12

(24%)

 8–10

38

(76%)

  1. PCa Prostate Cancer, BPH Benign Prostate Hyperplasia, PSA Prostate Specific Antigen